Topic: Led by the ERS Assembly 11: Thoracic oncology, this journal club will explore the “Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial”
Ref: Article: Lancet 2021 9;398(10308):1344-1357. DOI: 10.1016/S0140-6736(21)02098-5
Who can participate? This is an open online event. However, the topic will be of particular interest to the members of ERS Assembly 11: Thoracic oncology, as well as non-members who specialise in this area.
Access: This is a virtual event. No registration is required. To participate, simply click on the link at the top of the page at the date and time of the event.
More from this journal club? This journal club will take place on a monthly basis. An email with details of each journal club session will be sent to you in advance. The next journal club will take place on 26 May, 2022.